GL Pharm Tech Corp. (KOSDAQ:204840)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,230.00
+25.00 (0.59%)
At close: Aug 24, 2026

GL Pharm Tech Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,2533,0364,2584,1364,6396,189
Short-Term Investments
206.2-----
Cash & Short-Term Investments
3,4593,0364,2584,1364,6396,189
Cash Growth
100.22%-28.69%2.95%-10.86%-25.03%-34.78%
Accounts Receivable
6,4957,1085,8045,6185,5143,480
Other Receivables
-151.41214.16173.99156.25180.71
Receivables
6,4957,2596,0185,7925,6713,660
Inventory
10,98710,9568,5506,6405,5083,387
Prepaid Expenses
-3.195.392.14-0.2
Other Current Assets
270.48411.62182.2849.21372.1432.77
Total Current Assets
21,21221,66619,01416,61916,19013,270
Property, Plant & Equipment
20,94220,74018,12718,86419,85015,465
Long-Term Investments
3,2863,2893,0122,9923,0201,024
Other Intangible Assets
1,355527.43780.33819.281,0431,253
Long-Term Deferred Charges
-786.59899.65208.33435.8663.27
Other Long-Term Assets
2,2081,805573.19189.61144.75121.3
Total Assets
49,00448,81442,44039,86840,85431,895

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1,9902,4781,9702,5643,104623.4
Accrued Expenses
-1,273700.451,0171,707645
Short-Term Debt
12,8836,8422,9834,3802,0301,980
Current Portion of Long-Term Debt
3,2507,4005,6972,0004,350249.96
Current Portion of Leases
97.3486.3692.4677.9271.6888.82
Current Unearned Revenue
-15015033550-
Other Current Liabilities
3,4343,2152,3201,9451,7901,278
Total Current Liabilities
21,65421,44413,91412,31913,1044,865
Long-Term Debt
4,4204,1805,65011,2477,4005,450
Long-Term Leases
227.57224.47227.4979.9457.92109.94
Long-Term Unearned Revenue
-693.8893.8943.071,3131,032
Pension & Post-Retirement Benefits
114.37279.5177.21992.31689.01715.74
Long-Term Deferred Tax Liabilities
2,0532,0742,0102,0052,2002,243
Other Long-Term Liabilities
643.800-000
Total Liabilities
29,11428,89522,77227,58624,76414,415

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
7,7557,7557,6976,2356,2106,185
Additional Paid-In Capital
34,29934,29934,06725,61525,55825,795
Retained Earnings
-22,188-22,149-22,111-19,251-15,502-15,313
Treasury Stock
-0.11-0.11-0.11-0.11-0.11-0.11
Comprehensive Income & Other
23.3914.214.91-317.23-175.7182.01
Total Common Equity
19,89019,91919,66812,28216,09016,849
Minority Interest
-----630.18
Shareholders' Equity
19,89019,91919,66812,28216,09017,480
Total Liabilities & Equity
49,00448,81442,44039,86840,85431,895

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
20,87918,73314,65017,78513,9107,879
Net Cash (Debt)
-17,419-15,697-10,393-13,650-9,270-1,690
Net Cash Growth
------
Net Cash Per Share
-213.66-1017.61-689.15-1096.65-747.30-166.15
Filing Date Shares Outstanding
81.5315.5115.3912.4712.4212.37
Total Common Shares Outstanding
81.5315.5115.3912.4712.4212.37
Working Capital
-442.35222.225,1004,3013,0868,404
Book Value Per Share
243.961284.281277.72984.881295.451362.02
Tangible Book Value
18,53419,39118,88811,46315,04715,596
Tangible Book Value Per Share
227.341250.271227.02919.191211.451260.73
Land
-10,26610,26610,26610,2669,491
Buildings
-7,5307,5307,5307,5304,417
Machinery
-9,1948,7278,6748,1808,130
Construction In Progress
-541.6715.85-200254